siRNA, Anti-Human ACVR2A, LNA(CAT#: SIRGT04054WQ-LNA)

The product SIRGT04054WQ-LNA is a type of small interfering RNA (siRNA) that targets ACVR2A gene and regulates the expression of gene. The siRNA interferes with the expression of ACVR2A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001278579.1; NM_001278580.1; NM_001616.4
Alternative Names ACTRII; ACVR2
Related Diseases Fibrodysplasia Ossificans Progressiva, Multiple Synostoses Syndrome
Purification HPLC
Target Gene
Gene ID 92
Uniprot ID P27037

Related Products